Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Amyloidosis of Light Chain Type”

212 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 212 results

Early research (Phase 1)Active Not RecruitingNCT03283917
What this trial is testing

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Who this might be right for
Newly Diagnosed Primary AmyloidosisRecurrent Primary AmyloidosisRefractory Primary Amyloidosis
M.D. Anderson Cancer Center 21
Early research (Phase 1)Looking for participantsNCT05652335
What this trial is testing

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC 180
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)Ended earlyNCT02994784
What this trial is testing

Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients

Who this might be right for
Amyloidosis; Systemic
Boston Medical Center 27
Not applicableLooking for participantsNCT06205953
What this trial is testing

A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)

Who this might be right for
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 400
Very early researchNot Yet RecruitingNCT07615270
What this trial is testing

A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

Who this might be right for
AL Amyloidosis
Stanford University 5
Testing effectiveness (Phase 2)Study completedNCT01510613
What this trial is testing

Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis

Who this might be right for
Primary Amyloidosis of Light Chain Type
Fondazione IRCCS Policlinico San Matteo di Pavia 28
Early research (Phase 1)Ended earlyNCT03000660
What this trial is testing

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

Who this might be right for
AL Amyloidosis
Tufts Medical Center 3
Large-scale testing (Phase 3)Study completedNCT05184088
What this trial is testing

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Who this might be right for
Cardiac AmyloidosisAL AmyloidosisATTR Amyloidosis
Lantheus Germany GmbH 244
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Testing effectiveness (Phase 2)WithdrawnNCT05486481
What this trial is testing

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Who this might be right for
AL AmyloidosisLight Chain (AL) AmyloidosisSystemic Light Chain Disease
Alfred Chung, MD
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00883623
What this trial is testing

A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis

Who this might be right for
Primary Amyloidosis
Heidelberg University 50
Very early researchStudy completedNCT00424242
What this trial is testing

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Northwestern University 15
Large-scale testing (Phase 3)Study completedNCT00661999
What this trial is testing

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 502
Not applicableLooking for participantsNCT06855121
What this trial is testing

The Norwegian Immunotherapy in Multiple Myeloma Study

Who this might be right for
Myeloma MultiplePlasma Cell LeukemiaAL Amyloidosis
St. Olavs Hospital 400
Not applicableLooking for participantsNCT06455748
What this trial is testing

Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study

Who this might be right for
Amyloid Light-chain Amyloidosis
Yongyong MA 20
Testing effectiveness (Phase 2)Looking for participantsNCT07638683
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

Who this might be right for
Multiple MyelomaAL Amyloidosis
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01849783
What this trial is testing

Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma

Who this might be right for
Extramedullary PlasmacytomaIsolated Plasmacytoma of BoneLight Chain Deposition Disease+4 more
Margarida Magalhaes-Silverman 41
Testing effectiveness (Phase 2)Study completedNCT04617925
What this trial is testing

Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

Who this might be right for
AL Amyloidosis
Stichting European Myeloma Network 35
Load More Results